ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Millar, E.
Right arrow Articles by Thomson, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millar, E.
Right arrow Articles by Thomson, N.
Eur Respir J 1995; 8: 1838-1841
Copyright © ERS Journals Ltd 1995

Clinical Trial

Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo

EA Millar, JE Nally, and NC Thomson

Angiotensin II levels are elevated in patients with acute severe asthma. In addition, intravenous angiotensin II causes bronchoconstriction in mild asthmatic patients. In the present study, we examined the effects of this hormone on bronchi in vitro and its interaction with the cholinergic agonist methacholine both in vivo and in vitro. Contractions of rings of human bronchi were measured isometrically. Concentration-response curves were obtained to angiotensin II and to methacholine in the presence and absence of angiotensin II. In addition, seven asthmatic patients with mild bronchial hyperreactivity to methacholine received placebo, angiotensin II, 1 or 2 ng.kg-1.min, by infusion, followed by methacholine challenge. Forced expiratory volume in one second (FEV1) values were measured at baseline, at the end of the infusion and during methacholine challenge. Angiotensin II alone in vitro evoked small contractions of human bronchi ( < 0.25 g wt). Pre-incubation with low concentrations of angiotensin II significantly enhanced contractions to methacholine. In mild asthmatic patients, angiotensin II alone evoked no change in baseline FEV1 values at the levels studied. Compared to placebo, angiotensin II 2 ng.kg-1.min, but not 1 ng.kg-1.min, evoked a significant increase in bronchial reactivity to methacholine. Angiotensin II in subthreshold concentrations enhances methacholine-evoked bronchoconstrictions both in human in vitro and in mild asthmatic patients in vivo. Our findings suggest a novel role for angiotensin II as a putative mediator in asthma.


This article has been cited by other articles:


Home page
 ThoraxHome page
M. Schatz
Is maternal asthma a life or death issue for the baby?
Thorax, February 1, 2009; 64(2): 93 - 95.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Veerappan, A. C. Reid, R. Estephan, N. O'Connor, M. Thadani-Mulero, M. Salazar-Rodriguez, R. Levi, and R. B. Silver
Mast cell renin and a local renin-angiotensin system in the airway: Role in bronchoconstriction
PNAS, January 29, 2008; 105(4): 1315 - 1320.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Moldobaeva and E. M. Wagner
Angiotensin-converting enzyme activity in ovine bronchial vasculature
J Appl Physiol, December 1, 2003; 95(6): 2278 - 2284.
[Abstract] [Full Text]

Home page
 ChestHome page
M. Cazzola, P. Noschese, G. D'Amato, and M. G. Matera
The Pharmacologic Treatment of Uncomplicated Arterial Hypertension in Patients With Airway Dysfunction
Chest, January 1, 2002; 121(1): 230 - 241.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Tanaka, S. Teramoto, K. Oashi, T. Saikai, S. Tanaka, K. Suzuki, M. Hashimoto, and S. Abe
Effects of Candesartan on Cough and Bronchial Hyperresponsiveness in Mildly to Moderately Hypertensive Patients With Symptomatic Asthma
Circulation, July 17, 2001; 104(3): 281 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. MYOU, M. FUJIMURA, Y. KAMIO, Y. ISHIURA, K. KURASHIMA, H. TACHIBANA, T. HIROSE, and T. HASHIMOTO
Effect of Losartan, a Type 1 Angiotensin II Receptor Antagonist, on Bronchial Hyperresponsiveness to Methacholine in Patients with Bronchial Asthma
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 40 - 44.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. MYOU, M. FUJIMURA, K. KURASHIMA, H. TACHIBANA, K. WATANABE, and T. HIROSE
Type 1 Angiotensin II Receptor Antagonism Reduces Antigen-induced Airway Reactions
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 45 - 49.
[Abstract] [Full Text]

Home page
 ChestHome page
G. W. Chalmers, E. A. Millar, S. A. Little, M. C. Shepherd, and N. C. Thomson
Effect of Infused Angiotensin II on the Bronchoconstrictor Activity of Inhaled Endothelin-1 in Asthma
Chest, February 1, 1999; 115(2): 352 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. KANAZAWA, K. HIRATA, and J. YOSHIKAWA
Guinea Pig Airway Hyperresponsiveness Induced by Blockade of the Angiotensin II Type 1 Receptor . Role for Endogenous Nitric Oxide
Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 165 - 168.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. BARNES
Pharmacology of Airway Smooth Muscle
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S123 - S132.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S. McKay, J. C. de Jongste, P. R. Saxena, and H. S. Sharma
Angiotensin II Induces Hypertrophy of Human Airway Smooth Muscle Cells: Expression of Transcription Factors and Transforming Growth Factor-beta 1
Am. J. Respir. Cell Mol. Biol., June 1, 1998; 18(6): 823 - 833.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.